White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study

David Medina1, Leyla DeToledo-Morrell, Fabio Urresta

  • 1Department of Neurological Sciences, Rush University Medical Center, 1725 W. Harrison, Suite 309, Chicago, IL 60612, USA.

Neurobiology of Aging
|July 12, 2005
PubMed

Insights

White matter changes, measured by diffusion tensor imaging (DTI), are detectable in mild cognitive impairment (MCI) and Alzheimer's disease (AD). These microstructural alterations in white matter tracts occur before dementia onset.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomedical Engineering

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder.
  • Mild cognitive impairment (MCI) is a transitional stage preceding dementia.
  • White matter (WM) integrity is crucial for cognitive function.

Purpose of the Study:

  • To investigate white matter microstructural integrity in patients with AD and MCI.
  • To assess early WM changes using diffusion tensor imaging (DTI).
  • To compare WM integrity between AD, MCI, and healthy controls (NC).

Main Methods:

  • Diffusion tensor imaging (DTI) was employed to assess white matter.
  • Fractional anisotropy (FA), a DTI index of WM integrity, was calculated.
  • Voxel-by-voxel analysis compared FA values across groups (AD, MCI, NC).

Main Results:

  • Significant reductions in FA were observed in posterior WM regions for both MCI and AD groups compared to controls.
  • There was a notable overlap in the locations of reduced FA between MCI and AD participants.
  • These findings indicate early white matter microstructural compromise in MCI.

Conclusions:

  • White matter integrity is compromised in individuals with MCI, predating the development of dementia.
  • DTI is a sensitive tool for detecting early microstructural changes in AD and MCI.
  • Early detection of WM changes may aid in understanding disease progression and developing interventions.

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...